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Abstract.  BR 96 is an internalizing antibody that 
binds to Lewis Y  (LeY),  a  carbohydrate determinant 
expressed at high levels on many human carcinomas 
(Hellstr6m, I., H. J.  Garrigues, U. Garfigues, and 
K. E. Hellstr6m.  1990. Cancer Res.  50:2183-2190). 
Breast carcinoma cell lines grown to confluence bind 
less BR96 than subconfluent cultures (Garrigues, J., 
U. Garrigues, I. Hellstr6m, and K.  E. Hellstr6m. 
1993. Am.  J.  Path.  142:607-622).  However, when the 
confluent cells are induced to migrate by scratch 
wounding, they again bind BR96 suggesting that anti- 
gens bearing the Ley determinant may promote cell 
migration. In the present study, BR96 was found to be 
highly enriched on microspikes and ruffled mem- 
branes, cell surface structures involved in cell migra- 
tion. In addition, BR96 was a potent inhibitor of cell 
migration in vitro. When stationary BR96 treated cells 
were exposed to fresh culture media, membrane 
ruffles and microspikes developed at the cell margin 
and migration resumed. Immunogold microscopy 
showed that BR96 antigens were enriched on these 
membrane protrusions. 
BR96 cell surface immunoprecipitation analysis of 
3H-glucosamine labeled breast carcinoma cells 
identified antigens with approximate molecular weights 
of 135 kd (upper antigen) and 85 kd (lower antigen). 
A  short amino terminal sequence (8 residues) of the 
upper antigen matched that of human lysosomal mem- 
brane glycoprotein 1 (LAMP-l). In addition, the upper 
antigen was detected on immunoblots probed with 
anti-LAMP-l, and within the intracellular compartment 
BR96 was found predominantly in endosomes and 
lysosomes. 
A  soluble LAMP-1/immunoglobulin fusion protein 
(LAMP-1/Ig)  was transiently expressed in both BR96 
binding and nonbinding cell lines. Immunoblot analy- 
sis of LAMP-1/Ig's  from the various cell lines showed 
that (a) acquisition of the BR96 epitope is probably 
controlled at the level of polylactosamine modification 
(e.g., fucosylation) rather than LAMP-1  gene expres- 
sion; (b) alternate forms of LAMP-1/Ig comigrate with 
the lower BR96 antigen raising the possibility that it 
may be a degradation product of the upper antigen; 
and (c) LAMP-1/Ig expressed in 3396 breast carci- 
noma cells has approximately 30-fold more BR96 epi- 
topes than LAMP-1/Ig from non-tumorigenic mam- 
mary epithelial cells. Together these data indicate that 
a major BR96 antigen, LAMP-l, is present on unique 
cell surface domains involved in cell locomotion as 
well as membranes of the endocytic compartment. Al- 
tered glycosylation of LAMP-1  expressed in trans- 
formed cells may contribute to their ability to dis- 
seminate. 
M 
ANY ligands have been identified that can regulate 
cell locomotion (Turley, 1992). Some studies in- 
dicate that altered cell migration is associated with 
aberrant glycosylation.  In a  number of instances,  highly 
metastatic tumor cells were found to express more polylac- 
tosamine  oligosaccharides  (Gal/31-4GlcNAc/31-3), than 
normal or poorly metastatic ones (Hubbard,  1987; Pierce 
and Arango, 1986; Yamashita et al.,  1984; Yousefi et al., 
1991). Poly N-acetyllactosamine chains are often modified 
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with fucose and sialic acid to give rise to unique terminal 
structures  such as sialyl Lewis X (S-Lex).  ~  Recently, S-Le  x 
has been identified as a ligand for the selectin family of adhe- 
sion receptors which are important in leukocyte and en- 
dothelial cell interactions  in inflammation and possibly tu- 
mor cell metastasis (Bevilacqua et al., 1993). Other studies 
however indicate  that polylactosamines may promote cell 
migration through their ability to destabilize adhesion to the 
extracellular matrix (Laferte and Dennis, 1988). There is lit- 
1. Abbreviations used in this paper:  mw, molecular weight; S-Le x, sialyl 
Lewis X; TR,  anti-transferrin receptor. 
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amine containing molecules relative to cell/substratum con- 
tact points,  or other  membrane domains such as  ruffled 
membranes or microspikes which are known to be involved 
in migration (Trinkaus,  1985). 
BR96 is a mAb selected on the basis of its enhanced bind- 
ing to carcinomas relative to most normal tissues (Hellstrtm 
et al.,  1990).  Assays using defined oligosaccharides have 
shown that Lewis Y (Fuc or,2 Gal ilia [Fuc od,3] GlcNAc 
~1,3...),  a unique carbohydrate structure at the termini of 
polylactosamine oligosaccharides, is a critical structure rec- 
ognized by BR96 (Hellstrtm et al.,  1990).  We have also 
shown that BR96 can inhibit tumor cell growth, and when 
bound to adherent cells, is internalized via coated pits to en- 
dosomes,  multivesicular bodies,  and  finally, degraded in 
lysosomes (Garrigues et al., 1993). The fact that BR96 can 
effectively target the intracellular compartment has proved 
useful in therapy experiments where animals bearing estab- 
lished human carcinomas were cured after treatment with 
BR96  doxorubicin  immunoconjugates  or  Pseudomonas 
PE40 exotoxin fusion protein (Trail et al.,  1993; Friedman 
et al.,  1993). 
Studies looking at Ley expression and cell growth showed 
that carcinoma cells grown to confluence bind significantly 
less  BR96  than  subconfluent cultures  (Garrigues  et  al., 
1993).  Furthermore, when contact inhibition is broken by 
scratch wounding, cells growing out of the confluent region 
reexpress the BR96 antigen (Garrigues et al., 1993). These 
experiments suggest that either cell contact causes an inhibi- 
tion of  antigen expression or that the BR96 antigen is upregu- 
lated on migrating ceils. 
In the present study, we have investigated further the role 
of the BR96 defined Ley antigen in cell migration. We show 
that BR96 specifically localizes to microspikes and ruffled 
membranes at the cell surface, and, under conditions favor- 
ing mAb internalization, BR96 alters cell morphology and 
completely blocks cell migration.  The BR96 antigen was 
also isolated and its amino terminal sequence matched that 
of  LAMP-1 (for review see Fukuda, 1991). cDNA expression 
studies confirm that BR96 can bind to LAMP-l, and reveal 
that LAMP-1 derived from carcinoma ceils has significantly 
more BR96 epitopes than LAMP-1 expressed in non tumori- 
genic mammary epithelial cells. These data show that the 
potential functions of LAMP-1 are not limited to the biogen- 
esis of the lysosome. Instead, cell surface LAMP-1 partici- 
pates in cell migration, possibly by facilitating microspike 
formation or the development of cell/substratum contacts. 
Materials and Methods 
Antibodies and Cells 
The human breast carcinoma line 3396 and mAbs BR96,  anti-transferrin 
receptor (TR), and control anti-Pseudomonas aeruginosa flagellum (IIG5) 
have been described before (Garrigues et al., 1993) as has the human mam- 
mary  epithelial line  184  AIN-TH  (Clark  et  al.,  1988).  mAb H4A3  is 
specific for human LAMP-I (Mane et al.,  1989). 
Immunocytochemistry 
For cell surface labeling studies, cells were plated as described previously 
(Garrigues et al., 1993), fixed with 2% glutaraldehyde in PBS for 2 min, and 
then 8 % paraformaldehyde for 30 min at 25°C, washed, and treated with 
freshly prepared 0.1% NaBI-h  for 30 min. Nonspecific binding sites were 
blocked with PBS containing 5% BSA, 3% normal human serum, 1% normal 
goat serum, and 0.5% gelatin (blocking buffer) for 1 h at 25"C. BR96 and 
TR were directly conjugated to 15-ran and 10-ran colloidal gold, respec- 
tively (Larsson,  1988),  and were diluted in diluent (blocking buffer/PBS 
1:4) to an approximate protein concentration of 0.1 t~g/ml. Gold-labeled 
mAbs (BR96/gold, TR/gold) were incubated for 16 h at 4"C, washed, fixed 
as above, washed in dH20, treated with fish skin gelatin (0.5% in dH20) 
for 30 min, and silver enhanced (Goldmark Biologicals, Phillipsburg, NJ) 
for 4  min at 25°C.  The slides were then washed extensively in distilled 
H20 and viewed by darldield microscopy. 
For SEM, cells were treated as above except silver enhancement was for 
8 min. The preparation was then air dried and coated with carbon. Images 
were detected either as secondary electron emissions or backscatter electron 
emissions at  10 kV using a  JSM 6300  F  scanning electron microscope 
(JEOL Ltd., Tokyo, Japan). 
For intracellular localization studies, fixed cells were permeabilized with 
0.5% Triton X-100 for 15 rnin and washed before the blocking step as de- 
scribed above. Instead of gold labeled mAbs, BR96/FITC (25 #g/ml) was 
used instead. The labeled preparation was mounted in Slowfade (Molecular 
Probes, Eugene, OR). 
Internalization Assays 
Cells were plated as described above, pulsed with TR/gold for 2 h at 37"C, 
briefly "squirt" washed, and chased at 37"C in Iscove's modified Dulbecco's 
media containing 15%  FBS (15%  IMDM) for 3 h. The cells were fixed, 
permeabilized, silver enhanced,  blocked, and prepared for BR96/FITC im- 
munofluorescence as described above. Gold and FITC-labeled probes were 
localized using simultaneous darkffeld and epifluorescence. The objective 
was equipped with an iris. The darldield light source was set at 4.5 V. The 
epifluorescence filters were exciter BP 485/520,  dichromatic FT 510, and 
barrier LP 520 (Carl Zeiss, Inc., Thornwood, NY). Images were recorded 
on Fuji P1600 film (ASA 1600)  using 63x  and 100x  objectives. 
For ultrastructural studies cells were pulsed and chased with TR/gold as 
described above, and then fixed in 2 % glntaraldehyde for 30 rain. They were 
subsequently embedded in Medcast resin and thin sections were collected 
on copper grids coated with formvar. 
For the transferrin receptor degradation studies, cells (5  x  105/35-mm 
dish) were pulsed and chased with 12SI-TR (25 #g/ml) as described above. 
At the end of the chase period, the media were collected, the dishes were 
extensively washed and the ceils lysed with TNEN (20 mM Tris-HCl buffer, 
pH 8.0, containing 100 mM NaC1,  1 mM EDTA, 1 mM PMSF, 1% aproti- 
nin, and 0.5% NP-40) for 20 min at 4°C. Aliquots from the media and cell 
fractions were counted in a gamma counter and analyzed on nonreducing 
10% tricine gels (Novex, San Diego, CA). A phosphoimager (Molecular 
Dynamics, Sunnyvale, CA) was used to quantitate relative intensity of in- 
dividual bands on gels. 
Migration Assays 
3396 cells were plated on plastic slides (105 cells/slide) as described (Gar- 
rigues et al., 1993). After culturing for 24 h, the monolayers were scratched 
and multiple images (n =  6) along the wound were recorded (t =  0 h) using 
the  Image  I  image  analysis  software  (Universal  Imaging  Corp.,  West 
Chester, PA) and a Nikon microscope equipped with a 4x objective. The 
cultures were immediately treated with various concentrations of BR96 or 
IIG5 control mAb diluted in 15%  IMDM. After an overnight incubation, 
the cells were cultured  for an additional 48  h  with mAbs which were 
replaced twice daily with fresh mAbs. The cells were fixed for 2 h with 2 % 
glutaraldehyde in PBS and stained with Coomassie Blue. Multiple images 
along the wound at positions used for t  =  0 h were recorded (t =  65 h). 
The images at t =  0 h and t =  65 h were used to quantitate the area within 
the wound, lacking cells. For each position the area difference (i.e., the area 
at t =  0 h minus the area at t -- 65 h) was determined. The data is presented 
as the percent migration by comparing area differences for BR96 (or IIG5) 
treatment to area differences for 15% IMDM treatment. 
Antigen Isolation and Characterization 
3396  cells were lysed with TNEN as above.  The lysate was chromato- 
graphed on a U/ex eumpeus I lectin column (2 ml bed vol) equilibrated with 
PBS containing 0.5% NP-40 (PBS/NP-40). The column was washed and 
ehted with PBS/NP-40 containing 10% fucose. The second fraction (1 ml 
each) was iodinated (2 mCi) with iodobeads (Pierce, Rockford, IL) for 15 
rain at 25°C.  Labeled proteins eluting in the void volume of a  Sephadex 
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column (mAb HG5, 20 mg/2 rni column). After a l-h incubation at (4°C), 
unbound proteins were collected and added to a mAb BR96 affinity column 
(20 nag/2 ml gel). The column was incubated at 4°C for 1 h, washed with 
TNEN, and eluted with triethylamine pH 11.5. Eluates were immediately 
neutralized with 1 M  Tris/HC1  pH 4.15  and analyzed by SDS-PAGE on 
7.5-15% gradient gels. 
For call surface immunoprecipitation experiments, 3396 cells were la- 
beled for 36 h with 400/zCi [3H]glucosamine diluted in 15 % IMDM. The 
cells were washed with ice cold media and treated with BR96 (50/zg/ml) 
or control mAb for 1 h at 40C.  Unbound mAb was removed by washing 
(4°C) and the cells lysed as described above. The lysate was cleared by cen- 
trifugation (400 g).  Rabbit anti-mouse IgG (50/~g) and Staphylococcus 
aureus 050-/~1 packed volume) were added to the lysate. The mixture was 
rotated for 1 h at 4°C. The Staphylococcus aureus were washed in TNEN 
and boiled in reducing sample buffer to dissociate the immune precipitates. 
The samples were analyzed by SDS-PAGE using 10% tricine gels. 
Proteins corresponding to potential BR96-defined antigens were identi- 
fied by comparing protein bands stained with Coomassie blue from 3396 
lysates that comigrated with [3H]glucosamine labeled, BR96 cell surface 
immunoprecipitated antigens. The BR96 antigens were purified by prepara- 
tive SDS-PAGE and electroelution using 6% tris glycine gels (Novex, San 
Diego, CA). The gels were stained for 15 min with 0.5% Coomassie blue 
diluted in H20. Protein bands migrating at 140, 135, 85, and 80 kd were 
excised and cut into l-ram cubes. The gel pieces were soaked in tris glycine 
running buffer for 1 h and electroeluted at 200 V for 2 h using an apparatus 
from Am_icon (Beverly,  MA).  Protein bands were also labeled with  z25I 
using the chloramine T method (McConahey and Dixon, 1980).  Labeled 
proteins were electrophoresed on 10% tricine gels and either analyzed by 
autoradiography to assess their purity or immunoblotting. In the latter case, 
proteins were transferred to Problot (Applied Biosystems, Foster City, CA) 
according to Hirano et al. (1990).  The transfers were blocked in blotto for 
1 h and incubated with control mAb, BR96, or anti-LAMP-1 for 16 h at 4°C. 
The immunoblots were washed and incubated with alkaline phosphatase- 
labeled goat anti-mouse IgG (Tago, Burlingame, CA) diluted (1:1,000) in 
blotto for 2 h.  The transfers were washed and developed using Western 
Blue, Promega, (Madison, WI). 
Amino terminal sequence data was obtained for the 135-kd protein iso- 
lated from 24 preparative gels as described above or by BR96 affinity chro- 
matography as follows, mAb IIG5 (2 nag) and BR96 (20 mg) were coupled 
to 1 ml and 7 ml, respectively, of AminoLink coupling gel as specified by 
the manufacturer (Pierce, Rockford, IL). Fifty ml of  packed 3396 cells were 
solubilized in TNEN buffer (see above) and passed over the IIG5 column. 
The nonbinding cell lysate was mixed with the BR96 affinity gel and rotated 
for 16 h at 4*C. The gel was collected in a  10-nil column fitted with a bed 
support.  The BR96 affinity column was washed with 50 ml TNEN and 
eluted with 10 ml of triethylamine pH 11.5. The eluate was neutralized with 
1 M Tris HC1 pH 4.15  and concentrated to 3 ml by speedvae. The eluate 
was electrophoresed on four 10% tricine gels. The region of the gel from 
100 kd to 180 kd was excised and electroeluted as described above. The elu- 
ate was concentrated to 40/zl, electrophoresed and transferred to Problot 
as above. A small piece of the blot was subjected to BR96 immunoblotfing, 
the remainder was stained with Coomassie blue. The 135-kd  band which 
comigrated with the BR96 immunoreactive band was sequenced by G. M. 
Hathaway,  Ph.D.,  Biotechnology Instrumentation Facility,  University of 
California, Riverside, CA. 
Plasmid Construction 
RNA was isolated from 3396 cells using reagents from Stratagene (La Jolla, 
CA), cDNA was synthesized  using a Gene Amp RNA PCR kit (Perkin Elmer, 
Norwalk, CT) using a primer (primer 1) starting at nucleotide 1296 (*) of 
LAMP-1  (Fukuda  et al.,  1988)  and having the sequence GTTCTCGTC 
TGATCACACTCCT  CCACAGAGC*  and containing a  Bcl I  site (under- 
lined). Nucleotide 1312 was removed to allow reading alignment of LAMP-1 
with Ig in the fusion construct (see below). Reactions contained 1/~g of 
RNA,  10 pmol of primer,  1 U RNase inhibitor, 10 mM dNTP's, 5 mM 
MgCI2, and lx PCR II buffer. The samples were heated to 94°C for 2 min 
and cooled to 41"C. Reverse transcription was carried out for 45 min at 41°C 
using 2.5 U M-MLV reverse transcriptnse. A LAMP-1 eDNA was amplified 
by PCR using primer 1 as the reverse primer and the oligonucleotide TGGA 
AAGCTTGATA'I~A*CCGTACCCGC~CGCCTCG  (the  Hind  HI  site  is 
underlined) corresponding to nucleotide 170 (*) of LAMP-I as the forv,  ard 
primer (primer 2). PCR reactions contained 50 pmol of primers 1 and 2 and 
2.5 U ofTaq polymerase. The thermocycler was run at 72°C for 15 min, and 
then for 33 cycles as follows: 1 rain 96°C, 2 min 60°C, and 2 min 72°C. 
Products of the PCR reaction were cleaved with restriction endonucleases 
(Hind HI and Bcl I) at sites introduced in the PCR primers and gel purified. 
The immunoglobulin (Ig) segment of the fusion construct corresponding 
to the human IgC'y1 was isolated from a pUC BT/Ig construct using restric- 
tion endonucleases Bcl I and Xba I as described (Linsley et al., 1991). The 
fusion construct was assembled by ligating Hind II//Bcl I cleaved Lamp-I 
fragment to the Bcl I/Xba I cleaved fragment containing IgC'rl sequences 
into the Hind IIl/Xba I cleaved 7rLN mammalian expression vector (pro- 
vided by A. Arutlb). Ligation products were transformed into DH10B/p3 
cells (GIBCO BRL, Gaithersburg, MD), and putative transformants were 
analyzed by restriction endonuclease digestion. Clones were sequenced 
using Sequenase version 2.0 (U.S. Biochemicals, Cleveland, OH). 
Transfection 
3396,  184AIN-TH,  3719 cells were transfected using the procedure of Seed 
and Aruffo (1987).  Cells were plated at 2.5  ×  106 per 150-ram  dish and 
cultured for 24-48 h. Plasmid DNA (25/~g/dish)  was added in 10 ml of 15 % 
IMDM containing 0.1 mM chloroquin and 0.5 mg/ml of DEAE Dextran. 
The cells were incubated for 2.5-3 h at 37°C, shocked for 2 rain with 10% 
dimethyl sulfoxide in PBS, washed, and incubated in IMDM for 24 h. The 
culture media was replaced with low serum (0.1%) IMDM which was col- 
lected 2-3 times at four day intervals. 
Purification of  lg Fusion Protein 
Ig fusion proteins were purified on immobilized protein A (Repligen Corp., 
Cambridge, MA). The affinity matrix was incubated for 1 h in blotto to 
block nonspecific protein adsorption, washed extensively with PBS, eluted 
with 0.1 M sodium citrate buffer, pH 2.2, and reequilibrated with PBS. The 
immobilized protein A (0.1 ml) was added to culture medio (20 nd) collected 
from the transfected cells, rotated for 16 h at 4°C and poured into a dispos- 
able column. The column was washed with PBS (5  x  1 ml) and eluted as 
described above. Fractions (200 t~l) were immediately neutralized with one 
third volume of 1 M "Iris, pH 11.0. Protein concentrations were determined 
by ELISA using chimeric L6 (Fell et al., 1992) as a standard. In some cases, 
the LAMP/Ig fusion proteins were concentrated on a Ultrafree MC mem- 
brane (Millipore, Bedford, MA). Purified fusion proteins were analyzed by 
immunoblotting as described above and the sequence of the first eleven 
amino terminal residues was determined to verify proper signal peptide 
cleavage. 
BR96 epitope density on LAMP-1/Ig's expressed in different cell lines 
was determined by ELISA. Immulon plates (Dynatech Laboratories, Chan- 
filly, VA) were coated with various concentrations of LAMP-1/Ig,  blocked 
with blotto, and incubated with either BR96,  IIGS,  or mouse anti-human 
IgGl (Caltag, San Francisco, CA) at 5 pg/rnl for 16 h at 4°C. The plates 
were washed 5 x  (PBS/0.05 % Tween) and incubated with a horseradish per- 
oxidase-labeled goat anti-mouse IgG/M (Tago) diluted 1:1,000 for 2 h. The 
plates were washed as above. Diluent buffer and chromogen substrate came 
from Genetic Systems Corp.  (Redmond, WA). 
Results 
BR96 Localizes to Distinct Cell Surface Domains: 
Microspikes and Membrane Ruffles 
3396 cells were fixed and surface labeled with BR96/gold. 
The preparation  was viewed by darkfield microscopy (Fig. 
1). Labeled cells appear pink/red similar to the color of the 
BR96/gold complex (Fig. 1). Areas of membrane not labeled 
are dark green/blue (Fig. I a, open arrow). Large accumula- 
tions of BR96 appear  as bright spots (Fig.  1, arrowhead). 
Note that on individual cells, distinct membrane domains are 
visible based on color differences generated by BR96 bind- 
ing. For example, at the cell margin, areas of ruffled mem- 
brane are pink/red (Fig.  1, a and b arrow) and express more 
BR96 antigen than the adjacent  smooth membrane which is 
green/blue. The perinuclear distribution  of the bright spots 
representing focal concentrations of gold suggests that BR96 
is associated preferentially  with microspikes (Fig.  1, a and 
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calization.  Fixed  3396  ceils 
were stained with BR96/gold 
and viewed by darkfield mi- 
croscopy. Bright spots repre- 
sent  focal  accumulations  of 
BR96  (arrowheads).  Unla- 
beled membrane regions are 
dark  green/blue  (Fig.  1  a, 
open arrow). At the cell mar- 
gin,  BR96 labeled  ruffled 
membranes are pink/red (ar- 
rows). BR96 is expressed at 
the leading lamella of migrat- 
ing cells (Fig.  1 c, open ar- 
row). Bar, 25 #m. 
b, arrowheads). Occasionally single migrating cells were ob- 
served (Fig. 1 c). In this case BR96 showed a polarized dis- 
tribution being associated with the leading lamella (Fig. 1 c, 
open arrow) while other membrane areas were labeled much 
less. 
To investigate the cell surface in more detail, BR96/gold- 
labeled cells were examined by SEM. Fig. 2 a shows the sur- 
face detail of a number of gold-labeled cells as well as one 
antigen negative cell (see Garrigues et al.,  1993) which is 
distinguished by having poorly resolved surface structures 
(Fig. 2 a, arrow). Note that on the BR96 labeled cells the 
ruffled membrane at the cell margin (Fig. 2 a, open arrow) 
and the prominent microspikes (Fig. 2, a and b, arrowheads) 
are  distinct  against  a  dark background  due  to  the  signal 
generated by the gold-labeled BR96. When using backscatter 
(Fig. 2 c) to preferentially detect higher energy electrons be- 
ing emitted by the gold probe, it is clear that the punctate api- 
cal cell surface labeling seen by light microscopy is due to 
BR96 binding to microspikes. Surface labeling studies, there- 
fore, show that BR96 is localized to both apical microspikes 
and ruffled membranes at the cell margin which represent 
distinct membrane domains.  The polarized expression on 
migrating cells suggests that the BR96 antigen may play a 
role in cell migration. 
IntraceUular Localization: The BR96 Antigen Is a 
Component of the Endosome/Lysosome Compartment 
Mammary epithelial cells 184 AIN-TH (184) express BR96 
antigens on the same cell surface protrusions as 3396 cells 
(see below), and were selected for intracellular antigen local- 
ization  studies  because  their fiat morphology resulted in 
higher resolution of BR96 within cytoplasmic compartments 
as compared to 3396. The 184 cells were fixed, permeabi- 
lized,  and  labeled with  BR96/FITC.  As  with  3396  cells, 
BR96 stained ruffled membranes at the cell margin (Fig. 3, 
open arrow) and microspikes (Fig. 3, arrowheads) at the sur- 
face of 184 cells. In addition, BR96/FITC labeled many vesi- 
cles  which  were distributed  from the  cell  margin  to  the 
perinuclear region (Fig.  3, arrow). 
To determine if these vesicles were part of the endocytic 
pathway,  pulse/chase studies using ~25I TR and double label 
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ceils were labeled with BR96/gold, dried, coated with carbon, and 
viewed by scanning electron microscopy detecting either secondary 
(a and b) or backscattered (c) electron emissions. The ruffled mem- 
branes at the cell margin (Fig. 2 a, open arrow)  and the prominent 
microspikes (arrowheads)  are very distinct due to electron emis- 
sions from the gold probe. The microspikes ofaBR96 antigen nega- 
tive  cell  (arrow) lacking  the  gold  probe  however are  poorly 
resolved. Bar, 10 #m (a) and 1 #m (b and c). 
(TR/gold, BR96/FITC) immunochemistry were performed. 
184 cells were pulsed for 2 h with 12sI TR at 37°C, washed, 
and chased for 3  h  at 37°C.  The media fraction was col- 
lected, and  the cells solubilized with detergent.  Approxi- 
mately 52 % of  the radiolabel was found in the media fraction 
(Fig. 4 a). Analysis by SDS-PAGE (Fig. 4 b) showed that a 
significant proportion of the TR had undergone degradation 
(18 kd, 71%) relative to the untreated TR (180 kd). Similarly 
a portion of the cell associated TR had also been degraded 
(15 kd, 24%). In addition, ultrastructural immunogold mi- 
croscopy showed that the TR was predominantly localized to 
multivesicular bodies and lysosomes (Fig. 4 c, arrows). 
To see if BR96 labeled the same vesicles as TR, 184 cells 
were pulsed and chased with TR/gold as described above, 
fixed,  permeabilized,  and  stained  with  BR96/FITC.  The 
cells were viewed using either epifluorescence alone(Fig. 5 
a) or with a  combination of epifluorescence and darkfield 
microscopy (Fig. 5 b). A significant number of the BR96 la- 
beled vesicles (Fig.  5 a, arrows) also contained colloidal 
gold (Fig. 5 b, arrowheads). Therefore, within cells, BR96 
recognizes  an  abundant  protein  associated  with  vesicles 
identified  in  pulse/chase  studies  as  endosomes  and  lyso- 
somes. 
BR96 Inhibits Cell Migration 
Localization of BR96 to microspikes and ruffled membranes 
combined with our previous observation that BR96 binds 
more to cells growing out of a scratch wounded culture (Gar- 
rigues et al.,  1993) suggests that the BR96 defined antigen 
is involved in cell migration.  To gain insight into antigen 
function, cells were cultured with BR96 under conditions 
which favor mAb internalization as a means of decreasing 
cell surface antigen concentrations (Drebin et al.,  1985). 
Cultures of 3396 cells were scratch wounded and grown for 
•65  h in the presence of various concentrations of BR96 or 
IIG5 control mAb. Cell migration was quantitated by mea- 
suring cell free regions of the scratch before and after mAb 
treatment and the distance migrated expressed as a percent- 
age relative to the media control. The morphology of cul- 
tures treated with 10 #g of BR96 (a) or IIG5 (b) and stained 
with Dapi is shown in Fig. 6. The white line (t =  0 h) is a 
tracing of the wound edge just before mAb treatment. The 
migration of BR96 treated cells was  completely blocked. 
Note at the wound edge in (a) many nuclei are above the im- 
age focal plane (arrow) indicating cell aggregation. In con- 
trast, control mAb-treated cells (b) have migrated to fill in 
the wound and clearly were not aggregated. A quantitative 
assay (Fig. 6 c) shows the dose dependence of BR96 induced 
inhibition  of migration.  Cell  locomotion was  completely 
blocked using 5-20 #g of BR96. Other internalizing mAbs 
(BRll0, BRlll) which bind to 3396 cells but do not recog- 
nize Ley, had no effect on cell migration (data not shown). 
In addition BR96 was not cytotoxic since cell migration re- 
sumed when BR96 was replaced with fresh culture media. 
Within  24  h,  the  cells  at  the  wound  edge had  extended 
numerous microspikes onto the substratum. BR96/gold im- 
munochemistry  showed that  these  structures in  many  in- 
stances  contained more antigen than adjacent cell bodies 
(Fig. 6 d). The data shows, therefore, that when BR96 is in- 
ternalized, cell morphology at the wound edge is altered and 
migration ceases. Upon BR96 removal, new antigen positive 
microspikes appear at the margin and cell locomotion re- 
sumes. The BR96 antigen, therefore, may contribute directly 
to cell migration or it may be essential for maintaining a 
morphology which is conducive to cell migration. 
BR96 Recognizes a Lysosomal Membrane Glycoprotein 
Expressed at the Cell Surface 
Previously we showed that fucose is a critical residue in the 
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stained with BR96/FITC. BR96 localized to ruffled membranes at the cell margin (open arrow), microspikes (arrowheads),  and to vesicles 
(arrows)  found throughout the cytoplasm especially in the perinuclear region. Bar, 20 #m. 
Figure 4. Internalization of an 
anti-transferrin receptor mAb. 
184 mammary epithelial cells 
were pulsed with 125I TR for 
2  h,  washed,  and chased for 
3 h at 37°C. Aliquots from the 
culture  supematants  (media) 
and the cell layer (cell) were 
collected and  quantitated by 
gamma counting  (a)  or ana- 
lyzed by SDS-PAGE to moni- 
tor  degradation  (b).  Similar 
pulse/chase experiments with 
TP-dgold  were  prepared  for 
electron microscopy (c). Note 
the  TR/gold  accumulated 
within  multivesicular  bodies 
(Fig. 4 c, right arrow) or elec- 
tron dense lysosomes (Fig. 4 c, 
left arrow). Bar C, 0.2 #m. 
The Journal of Cell Biology,  Volume 125, 1994  134 Figure 5.  BR96 colocalizes with internalized TR.  184 mammary epithelial cells were pulsed and chased with TR/gold as for Fig. 4, fixed, 
permeabilized, and stained with BR96/FITC. Epifluorescence alone (a). Combination of epifluorescence and darkfield microscopy (b). Note 
that many BR96 labeled vesicles (Fig. 5 a,  arrows) also contain internalized TR (Fig. 5  b, arrowheads).  Bar, 20/~m. 
Garrigues et al. Antibody BR96 Blocks Cell Migration and Binds to LAMP-1  135 Figure 6.  BR96 inhibits cell migration. Cultures of 3396 carcinoma cells were scratch wounded and treated with either BR96 (a) or IIG5 
control (b) for 65 h. The cells were fixed and stained with Dapi. The white line marks the location  of  the wound edge  just before mAb treatment. 
The arrows in a indicate areas of cell aggregation. The percent migration was calculated by measuring the change in area of the scratch which 
remained cell free after treatment with BR96 (solid line) or fIG5 (dashed line) as compared to media control (Fig. 6 c). In some experiments 
after BR96 treatment, the cells were cultured further (24 h) in 15 % IMDM without mAb and stained with BR96/gold (d, montage).  Note 
the prominent microspikes extending from the cell margin are heavily labeled with BR96/gold which appears dark brown; adjacent membrane 
regions (d, open arrows) are stained significantly less. 
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3396 carcinoma cells were chromatographed on a UEA I lectin col- 
umn. The column was washed and eluted with 10% fucose. The elu- 
ate was iodinated and applied to a BR96 affinity colanm (Fig. 7 a). 
The nonbindin~ fraction (lane 1) and the high pH eluate (lane 2) 
were analyzed on 7.5-15% gradient SDS/PAGE (Fig. 7 a). Cultures 
of 3396 cells  were metabolically labeled with  [3H]glucosamine, 
cooled, incubated with BIL06  at 4°C, washed, and solub'~ized with 
detergent. Anti-Ig was added to the lysate, the immune complexes 
precipitated with protein A and analyzed on 10% tricine gels or 6% 
tris glycine gels (Fig. 7 b). Autoradiographs were compared to gels 
of 3396 lysates stained with Coomassie blue (Fig. 7 b). BR96 anti- 
gens were purified on 6 % tris glycine  preparative gels, eleetroeluted, 
and aliquots of the purified protein were either iodinated or blotted 
and probed with BR96 (Fig. 7 c). 
antigen recognized by BR96 (Hellstr6m ~t al., 1990). Initial 
antigen purification schemes, therefore, used the fucose spe- 
cific lectin, UEA I in combination with mAb affinity chro- 
matography to identify BR96 antigens from 3396 cells. Ap- 
proximately ten fucosylated molecules ranging in molecular 
weight (mw) from <20 kd to >200 kd were isolated from 
3396 cells (Fig. 7 a, lane/). Two of the molecules with ap- 
proximate mw's of 135 kd and 85 kd bound specifically to 
the BR96 affinity column (Fig.  7 a, lane 2). To determine 
if either of these molecules were present on the cell surface, 
[3H]glucosamine-labeled cells were incubated with BR96 at 
4°C,  washed,  extracted with  detergent,  and  the  immune 
complexes precipitated with protein A.  Antigens from the 
intraceLlular compartment are, for the most part, excluded 
from the precipitation. As shown in Fig. 7 b, both the 135-kd 
Figure 8. BR96 recognizes LAMP-1. The 135-kd  BR96 antigen was 
purified by preparative electrophoresis or BR96 affinity chromatog- 
raphy as described above, electrotransferred to Problot  and the 
amino terminal sequence determined. At amino acids designated 
1,2,3 yields of  Arg, Glu, and Leu were also detected. The sequence 
of the 135-kd antigen was similar to human LAMP-1 and a mAb 
to LAMP-1 reacted strongly with the 140-kd and 135-kd antigens 
and less with the 85-kd and 80-kd antigens. 
and 85-kd antigens were precipitated; suggesting that both 
are cell surface receptors for BR96. A comparison of the im- 
munoreactive BR96  antigens  with  total  cellular  proteins 
stained with Coomassie blue (Fig. 7 b) identified a number 
of  bands which were sufficiently resolved on 6% gels for iso- 
lation purposes. Bands of 140 kd and 135 kd comigrated with 
the upper antigen band and proteins of 85  kd and  80 kd 
comigrated with the lower antigen (Fig. 7 b). The proteins 
were electroeluted from preparative gels and a portion la- 
be!ed with 125I to assess their purity. As shown in Fig. 7 c, 
left panel, each protein ran as a single band with the expected 
mw. Furthermore, each of the proteins expressed BR96 epi- 
topes  as  determined by  immunoblo~ing  (Fig.  7  c,  right 
panel). 
The upper antigen purified by BR96 affinity chromatography 
and the 135-kd antigen (10 pmol) isolated from preparative gels 
were electrotransferred to PVDF and the same amino termi- 
nal sequence of eight residues was obtained for both prepara- 
tions (Fig.  8 a). A search of the Genbank data base identified 
human LAMP-1 as having seven of eight matching residues. 
Furthermore the 140-kd and 135-kd BR96 antigens were rec- 
ognized on immunoblots probed with an anti-LAMP-1 mAb 
(Fig. 8 b). The 85-kd antigen reacted significantly less with 
the  mAb  and  the  80-kd  showed only trace levels of im- 
munoreactivity  (Fig.  8  b).  Since  the  anti-LAMP-1  mAb 
recognizes a core protein epitope (Mane et al.,  1989), it is 
possible that the 85-kd and 80-kd antigens represent degra- 
dation products of the mature  135/140-kd upper antigen. 
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epitOpe on the  85-kd and  80-kd antigens,  however,  since 
LAMP-1 is heavily glycosylated, these molecules retain mul- 
tiple carbohydrate epitopes recognized by BR96. 
Increased BR96 Epitope Density on 
LAMP-1 Expressed in Carcinoma Cells Relative 
to Nontransforraed Epithelial Cells 
The data presented above indicates that LAMP-1 expressed 
on the surface of tumor cells may promote cell migration. 
This raises the question whether LAMP-1 molecules from 
cells with different growth potentials are the same. Experi- 
ments were performed in which a soluble LAMP-FIg fusion 
construct,  consisting of the LAMP-1  extracellular domain 
ligated to human IgCT1  (Fig.  9  a) was expressed in both 
tumorigenic 3396 breast carcinoma cells and in 184 mam- 
mary epithelial cells which do not form tumors in nude mice 
(Clark et al., 1988). In addition, we assessed why some colon 
carcinoma lines, like 3719, are not recognized by BR96. Solu- 
ble  fusion proteins  were purified by protein A  Sepharose 
affinity chromatography and  analyzed by immunoblotting 
(Fig. 9 b). The LAMP-FIg fusion proteins isolated from the 
three cell lines had identical rows  (~,140 kd) and reacted 
equivalently with anti-human IgG (Fig.  9 b). The LAMP-F 
Ig's, therefore, appear to be glycosylated to the same extent, 
with carbohydrate accounting for 55 % of their mass. Fusion 
protein blots probed with BR96 gave a different pattern of 
immunoreactivity  as  compared  to  results  with  anti-IgG. 
First, LAMP-FIg's from 184 and 3396 were recognized by 
BR96 while that from the BR96 negative line 3719 was not 
(Fig. 9 b). Since the fusion protein produced in 3719 has a 
mass equivalent to those from 3396 and 184 cells, it suggests 
that minor carbohydrate differences may account for the lack 
of BR96 immunoreactivity. Second, LAMP-FIg produced in 
3396 cells was significantly more immunoreactive than the 
fusion protein produced in  184 cells.  This was not due to 
differences in  the  amount  of protein  present  since  blots 
probed with anti-human IgG and anti-LAMP-1 gave equiva- 
lent signals  with LAMP-FIg's expressed in  184  and 3396 
cells. Third, a number of lower mw species were detected 
in 3396 cells, the major one of which migrated at a position 
(85 kd, arrow) identical to one of the cell surface immuno- 
precipitated antigens. 
We next quantitated the observed difference in BR96 epi- 
tope density on LAMP-FIg expressed in carcinoma cells vs 
epithelial cells. Dilutions of the various fusion proteins were 
used to coat ELISA plates. The wells were incubated with 
either BR96, mouse monoclonal anti-human IgG, or control 
mouse IgG (5 #g/ml). Bound mAbs were detected with horse- 
radish peroxidase-labeled goat anti-mouse IgG. The data re- 
flect what is seen on the immunoblot. LAMP-FIg expressed 
in 184 cells reacted equivalently with both anti-human IgG 
and BR96 indicating a  similar epitope density for both of 
these mAbs.  On the other hand, it was necessary to dilute 
LAMP-FIg isolated from 3396 cells 30-fold relative to that 
from 184 cells to generate the same signal with BR96 (Fig. 
9 c). Data from transient expression studies, therefore, shows 
conclusively that the core protein of LAMP-1 can carry car- 
bohydrate  determinants  recognized  by  BR96  and  that 
LAMP-I  from mammary epithelial cells has  significantly 
fewer BR96 epitopes than LAMP-1 from breast carcinoma 
C 
EIR96/'3396 
2.oi  ~  .~,I, BR96/184 
8  , 
/.  control/184 
o.o  .....  , 
.0OOl  .OOl  .01  .1  1  lO 
LAMP-1/Ig  (p-g/ml) 
Figure 9.  BR96 binding to LAMP-FIg fusion proteins. A cDNA 
coding for  the LAMP-1 signal peptide (SP) and 98 % of  the LAMP-1 
extracellular domain (LAMP-/) was fused to a cDNA coding for the 
hinge, CH2, and CH3 domains of human IgC'y1, cloned into the 
vector ~r LN (Fig. 9 a) and transiently expressed in mammary epi- 
thelial cells (184), breast carcinoma cells (3396), or colon carci- 
noma cells (3719). Soluble fusion proteins were purified on protein 
A, run on 10% tricing gels, electrotransferred, and the blots probed 
with anti-human Ig, BR96, anti-LAMP-l, or IIG5 control (Fig. 9 
b). CTLA4/Ig produced in Cos cells served as a fusion protein con- 
trol. Note that the quantity of fusion protein analyzed from 3396 
and 184 were equal based on ELISA (not shown) and comparable 
reactivity with anti-Ig and anti-LAMP-1 (Fig. 9 b). BR96 reacted 
significantly more with LAMP/Ig from 3396 cells (BR96  blot, lane 
3) relative to LAMP-FIg from 184 cells (BR96arrow, lane 2). Also 
alternate forms of  LAMP-FIg produced by 3396 cells were detected 
with BR96, the major one migrated at 85 kd (BR96  blot, lane 3, ar- 
row).  The  apparent  difference  in  BR96  epitope  density  on 
LAMP-FIg expressed in  184 and 3396 cells was quantitated by 
ELISA (Fig. 9 c). 
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in which LAMP-1 influences cell migration in different cell 
types. 
Discussion 
BR96 is an internalizing mAb which recognizes an antigen 
highly expressed on carcinoma cells and has, therefore, been 
used to effectively  deliver drugs and toxins to tumor in mice 
and rats resulting in complete tumor eradication (Friedman 
et al., 1993; Garrigues et al., 1993; HellstrSm et al., 1990; 
Trail et al.,  1993).  Previously we showed that the level of 
BR96 antigen expression appeared to be controlled by cell 
density in that confluent cultures bound less BR96 than sub- 
confluent ones (Garrigues et al., 1993). However, when con- 
fluent cultures were scratch wounded, cells at the wound 
edge bound BR96 suggesting that antigen expression was ei- 
ther inhibited by cell contact or upregulated when cells were 
stimulated to migrate (Garrigues et al., 1993). To investigate 
these possibilities further, we have now studied the distribu- 
tion of BR96 at the cell surface and have looked at the effect 
of BR96 internalization on cell behavior. 
A  number of findings are consistent with the idea that 
BR96 recognizes an antigen which is involved in migration. 
First, localization studies using both light and scanning elec- 
tron microscopy showed that BR96 is highly enriched on 
mirospikes and ruffled membranes. Cells induced to migrate 
by chemotactic factors or scratch wounding rapidly develop 
membrane ruffles and microspikes (filopodia) which con- 
tinuously extend and retract as the cell advances (Guirguis 
et al., 1987; Trinkaus, 1985).  These membrane protrusions 
contain parallel bundles of actin filaments which gives them 
tensile strength and are enriched for cytoskeletal associated 
proteins, e.g., villin, fimbrin, talin, a-actinin, ezrin family 
members (Bretscher,  1991; Small, 1988);  ECM and growth 
factor receptors, e.g., fibronectin, laminin (Guirguis et al., 
1987), transferrin (Hopkins, 1985); signal transduction mole- 
cules, e.g., G proteins (Lewis et al., 1991); and others, e.g., 
melanoma chondroitin sulfate proteoglycan (Garrigues et al., 
1986),  CD43  (Yonemura et al.,  1993),  p185  n"u (Carothers 
Carraway et al.,  1993),  glucose transporter  (Orci  et al., 
1989), and GAP-43 (Widmer and Caroni, 1993). These struc- 
tures represent distinct functional microdomains of the cell 
surface.  Microspikes, for example,  can mediate centripetal 
particle movement and have a surveying function capable of 
guiding cells onto favorable  substrates or away from other 
cells, i.e., contact inhibition (Albrecht-Buehler,  1976; Fisher 
et al., 1988). In addition, microspikes are the precursor struc- 
tures of focal adhesions and therefore play a pivotal role in es- 
tablishing  links  between the  ECM  and  the  cytoskeleton 
which, in many instances, are necessary for cell migration 
(DePasquale et al., 1987; Izzard and Lochner, 1980; Izzard, 
1988). 
We also found that BR96, when added to cells in culture, 
was a potent inhibitor of cell migration using conditions that 
favor mAb internalization. Assays to assess cell viability 
showed the inhibition of migration was not due to BR96 in- 
duced cell death (data not shown). When the inhibitory effect 
of BR96 was reversed by treating cells with fresh media, the 
onset of cell  migration coincided with the  appearance  of 
newly formed microspikes and ruffled membranes at the cell 
margin.  Subsequent  immunogold-labeling  studies  showed 
that these  protrusions  contained more BR96  antigen than 
other regions of the cell surface.  BR96 appears to affect cell 
migration by inhibiting the ability of cells to elaborate micro- 
spikes and larnellipodia.  This is consistent with the findings 
of Guirguis et al. (1987) who showed that these structures are 
required for cell migration. BR96 also has some features in 
common with the motility-inhibiting antibody, MIA-15-5 which 
has specificity for the H carbohydrate structure [Fucod,2 GalB 
I-R] and additionally reacts with Ley (Miyake and Hakomori, 
1991). Like BR96, MIA-15-5 blocked cell migration in vitro 
and it also inhibited experimental metastases in mice (Miyake 
and Hakomori, 1991). At the same time other anti-carbohy- 
drate mAbs (e.g., anti-H or anti-Ley) had no effect on cell 
migration indicating that mAb avidity and/or epitope position 
along the oligosaccharide chain may be important factors in 
determining  whether  mAbs  with  similar  specificities  can 
block cell migration. Miyake et al. (1992) have also looked at 
the binding of  MIA 15-5 to human tumors and related the data 
to patient survival (Miyake et al.,  1992).  The five year sur- 
vival  for patients  having primary lung carcinomas that ex- 
pressed the MIA-15-5 epitope was significantly  less (20.9% vs 
58.6%) relative to patients with antigen negative tumors (Mi- 
yake et al., 1992). Perhaps the carbohydrate structures which 
are recognized by mAbs like MIA-15-5 and BR96 promote in- 
vasiveness  and therefore adversely affect patient survival. 
Interestingly, BR96 also has a number of features in com- 
mon with a mAb to gp78 which recognizes autocrine motility 
factor (Nabi et al.,  1992).  For instance, they both bind to 
an antigen highly expressed in the endocytic compartment 
and on membrane protrusions, and both are internalized af- 
ter antigen binding. Yet they have opposite effects on cell 
migration, as BR96 inhibits and anti-gp78  stimulates this 
process. Nabi et al. have speculated that anti-gp78 probably 
enhances membrane flow to the leading edge and thus in- 
creases directed locomotion (Nabi et al.,  1992; Singer and 
Kupfer,  1986). It is not known if BR96 affects vesicle trans- 
port. Preliminary experiments however indicate that BR96 
causes  microfilament  fragmentation  which  undoubtedly 
resulted in the cell rounding observed in this study. The for- 
marion of membrane ruffles, microspikes, and the advance- 
ment of the leading edge by migrating cells in response to 
ligand/receptor  interactions  involves  the  breakdown  and 
reassembly of the cytoskeleton. Stossel (1989, 1990)  has 
proposed that ligand induced phosphatidylinositol turnover 
and cytosolic calcium fluxes regulate the activation of the 
actin-binding proteins, gelsolin and profilin, which in turn 
regulate actin filament cleavage and elongation (Lester and 
McCarthy, 1992).  Indeed, the over expression of a gelsolin 
cDNA in fibroblasts resulted in enhanced cell motility which 
was  dose  dependent  (Curmingham  et  al.,  1991). Other 
studies indicate that agonist mediated changes in the cyto- 
skeleton can be independent of intracellular calcium levels 
(Greenberg et al.,  1991; Hall et al.,  1989;  Sha'afi et al., 
1986) and involve GTP-binding proteins such as rac (Ridley 
et al.,  1992)  and rho (Ridiey and Hall,  1992).  Additional 
work will  address  what effect BR96  has  on  cytoskeletal 
modifications caused by gelsolin, profilin, intermediates in 
phosphatidylinositol metabolism, or whether the inhibitory 
effect of BR96 is mediated by small GTP-binding proteins. 
We have also presented a number of findings which indi- 
cate that LAMP-1 is a major cell surface glycoprotein bearing 
BR96 defined epitopes. First, BR96 recognizes a Ley epi- 
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which are abundant on LAMP-1. Second, BR96 is internal- 
ized and either cycle between an endocytic compartment and 
the cell surface or, is degraded in lysosomes with similar ki- 
netics as mAbs to chicken LAMP-1 (Garrigues et al., 1993; 
Lippincott-Schwartz and Fambrough, 1987).  Third, within 
the intracellular compartment, BR96 localizes exclusively to 
endosomes and lysosomes. Fourth,  the  NH2-terminal  se- 
quence of the 135-kd BR96 cell surface antigen was identical 
to  LAMP-1.  And fifth,  LAMP-FIg  fusion proteins  tran- 
siently expressed in Ley positive cell lines were recognized 
by BR96. 
Cell surface antigens immunoprecipitated with BR96 ran 
as diffuse bands with approximate mw's of 135 kd (upper an- 
tigen) and 85 kd (lower antigen). These broad antigen bands 
were further resolved into bands of 140 kd and 135 kd (upper 
antigen) and 85 kd (lower antigen) which most likely repre- 
sent "doublet" bands due to minor glycosylation differences 
as LAMP-1 is heavily glycosylated. Two pieces of data sug- 
gest that the lower antigen may be derived from the upper 
antigen possibly as a result of  degradation. First, the 140 and 
135 kd antigens isolated from preparative gels reacted sig- 
nificantly  more with anti-LAMP-1 mAb than the 85 kd form, 
and the 80-kd antigen was barely detected which might be 
due to a stepwise proteolytic loss of the anti-LAMP-1  core 
protein epitope (Mane et al.,  1989).  Second, although the 
major form of LAMP-FIg transiently expressed in 3396 cells 
migrated at 140 kd, BR96 immunoblots also revealed the 
presence of  a number of lower mw forms of LAMP-FIg (>46 
kd). Since the mass of the nonglycosylated fusion protein is 
~65 kd, and modification of polylactosamines to generate 
the Ley epitope is a late event in carbohydrate biosynthesis, 
it follows that the low mw glycosylated forms of LAMP-FIg 
recognized by BR96 may be generated via degradation of the 
mature (140 kd) fusion protein. Interestingly, the most abun- 
dant form of degraded LAMP-FIg had an identical size (85 
kd) as the lower antigen immunoprecipitated with BR96 fur- 
ther suggesting that the latter may be a degradation product 
of the upper antigen. Additional work will focus on identify- 
ing the lower BR96 antigen to determine whether it is related 
to LAMP-1.  In addition to LAMP-l, carcinomas are also 
known to have glycolipids which express  Lewis antigens 
(Hakomori, 1989).  A comparison of glycolipid and glyco- 
protein fractions from 3396 cells showed that the majority 
ofBR96 immunoreactivity  was associated with the glycopro- 
tein fraction (Wang, W.-C., unpublished data). While our 
data indicate that LAMP-1 is a major cell surface antigen rec- 
ognized by BR96 they do not exclude the possibility that 
BR96 could also bind other less abundant protein or glyco- 
lipid antigens. 
The cDNA expression studies also provide information 
about why some carcinomas fail to react with BR96.  The 
mass of the LAMP-FIg's from both BR96 antigen positive 
and negative cell lines was the same (140 kd) indicating that 
the different cell lines had glycosylated the fusion proteins 
equivalently. Immunoblots of LAMP-FIg from the BR96 
negative colon carcinoma cells however failed to react with 
BR96,  suggesting  that  minor  carbohydrate  differences, 
e.g., fucosylation, may control whether or not tumors react 
with BR96. From this data in addition to our previous obser- 
vations (Hellstrtm et al.,  1990),  it follows that Ley is the 
only structure recognized by BR96 and that polypeptide se- 
quences are not involved in mAb binding. BR96 recognition 
of tumors therefore is probably controlled at the level of 
polylactosamine modification rather  than  LAMP-1  tran- 
scription. 
Although the  function of LAMP-1  is  unknown,  some 
studies investigating changes in glycosylation associated with 
metastasis are consistent with the idea that LAMP-1  may 
promote cell migration (Saitoh et al., 1992).  Highly meta- 
static cells, for example, have more polylactosamine than 
those from normal or nonmetastatic cells (Hubbard,  1987; 
Pierce and Arango, 1986; Yamashlta et al., 1984; Yousefi et 
al.,  1991). Glycosylation mutants of a metastatic cell line 
which were deficient in/3 1,6 GlcNAc transferase V activity, 
a key enzyme in polylactosamine  biosynthesis, showed a loss 
of metastatic potential but remained tumorigenic (Dennis et 
al.,  1987).  Furthermore, when polylactosamine formation 
was inhibited with swainsonine, metastatic tumor cell inva- 
sion of human amnion basement membrane in vitro was 
blocked (Yagel et al., 1989) and tumor formation in vivo was 
reduced  (Dennis,  1986;  Humphries,  1986). On  the  other 
hand,  the  acquisition  of highly branched polylactosamine 
oligosaccharides resulted in increased cell surface expression 
of LAMP-1 and was associated with efficient tumor metasta- 
sis (Heffernan et al.,  1989).  In addition, studies looking at 
LAMP-1/ECM interactions demonstrated that the binding of 
LAMP-1 from the metastatic tumor MDAY-D2 to type I col- 
lagen was glycosylation  dependent and enzymatic removal of 
sialic acid, polylactosamine, or complete N-linked sugars 
resulted in enhanced binding to type I collagen, laminin, and 
fibronectin (Laferte and Dennis,  1988).  These results sug- 
gest that polylactosamines may stimulate cell migration by 
destabilizing cell adhesion. 
It has been difficult to propose a model for how polylac- 
tosamines could influence cell migration because of a lack 
of information concerning their distribution relative to cell/ 
substratum contact points or membrane domains involved in 
cell migration. We now show that LAMP-l, a prominent an- 
tigen recognized by BR96 and the major cell surface glyco- 
protein carrying polylactosamine oligosaccharides, is strate- 
gically situated on microspikes and ruffled membranes to 
affect the formation of focal contacts during the initial stages 
of cell migration.  The role of LAMP-1  in cell migration 
might be related to its participation in membrane vesicle 
transport. However its localization on actin rich structures 
and the fact that BR96 induced LAMP-1 modulation resulted 
in microspike retraction and cell rounding also suggests that 
LAMP-1 can interact with other molecules which may regu- 
late assembly of the cytoskeleton. If this interaction was re- 
stricted to cell surface LAMP-l, as opposed to that in endo- 
somes and lysosomes, the migration of transformed cells 
might be  preferentially affected since  they contain more 
LAMP-1 at the plasma membrane than normal cells. 
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